Definitive Contract HHSN261201300027C
Award Date 9/20/13
Potential Completion Date 3/16/15
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98103, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a $79,500 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Nortis Inc., a for-profit manufacturer of biotechnology products and services. The contract is for the provision of a Parvivo System, which is an organ-on-a-chip technology. The contract has no set-aside designation and was awarded in September 2020, with a completion date of September 2021. Nortis Inc. has received prior federal grant awards from agencies such as...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), awarded a $40,742.00 firm-fixed-price purchase order to Nanion Technologies Inc., a for-profit scientific instrumentation company. The contract is for the delivery of an Orbit Mini System with Vesicle Prep Pro, which are advanced biomedical research tools used for cellular research, drug discovery, and biophysical studies. Nanion Technologies Inc. is a trusted...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $142,843.00 firm-fixed-price purchase order to Hesperos, Inc., a leading company in organ-on-a-chip technology, to provide scientific testing services. The contract is for the target validation and therapeutic evaluation of drug compound TRND00601748-01 in NGLY1 deficient cell-based models, including motoneurons and neuromuscular junction models. This...
- This $17,020 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Curi Bio Inc., a small disadvantaged business manufacturer. The contract is for the delivery of 3D IPSC skeletal muscle media kits, which will support biomedical research and drug development programs at NCATS. Curi Bio has previously received other federal contracts and grants from the National...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Lynntech Inc., a small business. The contract is for the development of non-polydimethylsiloxane (PDMS) biocompatible alternatives for organs-on-chips, a topic under NCATS SBIR 2019 solicitation. The contract has a firm fixed-price of $225,000.00 and a completion date of January 31, 2020. Lynntech Inc. is a small business that...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Nanocellect Biomedical Inc., a for-profit organization, for a microfluidic cell sorter. The total potential value of the contract is $149,680.00, with a completion date of August 31, 2022. The contract does not have a set-aside designation. Nanocellect Biomedical is a biotechnology company that provides automated cell analysis, sorting, and dispensing equipment,...
- This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
- This federal contract award, valued at $34,276.75, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for the delivery of 3D liver microtissues composed of human primary hepatocytes, liver endothelial cells, and Kupffer cells, which will be used by NIDA's 3D Tissue Bioprinting Laboratory...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Environmental Health Sciences awarded a $3,220 firm fixed price delivery order contract to Tecniplast USA, Inc. under the NIH's Research Triangle Park multiple award contract vehicle. The contract has a period of performance through March 2026 and does not include any set aside designations. The delivery order is likely associated with the NIH's research efforts focused on understanding the effects...
This is a $299,986.00 firm-fixed-price contract awarded by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to Nortis Inc., a small business manufacturer of biotechnology products and services. The contract is for administrative support services, which is designated as a total small business set-aside. Nortis Inc. has previously received federal grants and contracts from agencies such as the National Institute of Environmental Health Sciences and the National Center for Advancing Translational Sciences to develop organ-on-a-chip and microphysiological systems for applications including toxicology studies and COVID-19 research.
Generated 11/24/24, 9:28 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS | PHS-2013-1 | Department of Health and Human Services National Institutes of Health | Award Notice 1/2 | 7/30/12, 11:08 AM | |
SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION FOR SMALL BUSINESS INNOVATION RESEARCH CONTRACT PROPOSALS | PHS2013-1 | Department of Health and Human Services National Institutes of Health | Award Notice 2/2 | 11/1/12, 4:17 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | $0 | 3/16/15 | |
| 1 | Supplemental Agreement for work within scope | $0 | 1/21/14 | |
| Not listed | Not listed | $300.0k | 9/16/13 |